Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Gulfcoast Clinical Research Center
mi
from
Fort Myers, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Gulfcoast Clinical Research Center
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Innova Clinical Trials
mi
from
Miami, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Innova Clinical Trials
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Combined Research Orlando Phase I-IV LLC
mi
from
Orlando, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Combined Research Orlando Phase I-IV LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Olympian Clinical Research
mi
from
Tampa, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Olympian Clinical Research
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
The University of South Florida Board of Trustees, A public Body Corporate, for University of South Florida
mi
from
Tampa, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
The University of South Florida Board of Trustees, A public Body Corporate, for University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Northwest Behavioral Research Center
mi
from
Marietta, GA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Northwest Behavioral Research Center
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
AMR Baber Research Inc.
mi
from
Naperville, IL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
AMR Baber Research Inc.
mi
from
Naperville, IL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric Associates
mi
from
Overland Park, KA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric Associates
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Louisiana Clinical Research
mi
from
Shreveport, LA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Louisiana Clinical Research
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Sheppard Pratt Health System
mi
from
Baltimore, MD
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sheppard Pratt Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Univ of Massachusetts Med School
mi
from
Worcester, MA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
St. Charles Psychiatric Associates - Midwest Research Group
mi
from
Saint Charles, MO
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
St. Charles Psychiatric Associates - Midwest Research Group
mi
from
Saint Charles, MO
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Alivation Research
mi
from
Lincoln, NE
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Alivation Research
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Healthy Perspectives - Innovative Mental Health Services
mi
from
Nashua, NH
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Healthy Perspectives - Innovative Mental Health Services
mi
from
Nashua, NH
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Global Medical Institute, LLC
mi
from
Princeton, NJ
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Global Medical Institute, LLC
mi
from
Princeton, NJ
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Bio Behavioral Health
mi
from
Toms River, NJ
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Bio Behavioral Health
mi
from
Toms River, NJ
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Manhattan Behavioral Medicine, LLC
mi
from
New York, NY
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Manhattan Behavioral Medicine, LLC
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Fieve Clinical Research
mi
from
New York, NY
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Fieve Clinical Research
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
New Hope Clinical Research
mi
from
Charlotte, NC
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
New Hope Clinical Research
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Dr. Cherian Verghese
mi
from
Norristown, PA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Dr. Cherian Verghese
mi
from
Norristown, PA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Research Strategies of Memphis, LLC
mi
from
Memphis, TN
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Research Strategies of Memphis, LLC
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
North Texas Clinical Trials
mi
from
Fort Worth, TX
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
North Texas Clinical Trials
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric And Behavioral Solutions
mi
from
Salt Lake City, UT
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric And Behavioral Solutions
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia
mi
from
Charlottesville, VA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric Alliance of The Blue Ridge
mi
from
Charlottesville, VA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric Alliance of The Blue Ridge
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Houston Clinical Trials, LLC
mi
from
Bellaire, TX
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Houston Clinical Trials, LLC
mi
from
Bellaire, TX
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Research Centers of America
mi
from
Hollywood, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Research Centers of America
mi
from
Hollywood, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Little Rock, AR
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Ventura, CA
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Ventura, CA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Gainesville, FL
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Miami, FL
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Miramar, FL
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Miramar, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Atlanta, GA
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Wichita, KA
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Baltimore, MD
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Boston, MA
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Flowood, MS
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Flowood, MS
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Marlton, NJ
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Marlton, NJ
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Princeton, NJ
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Princeton, NJ
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Chapel Hill, NC
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Charlotte, NC
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Study Site
mi
from
Raleigh, NC
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Study Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Columbus, OH
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Philadelphia, PA
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Charleston, SC
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials